Evidence map›Paper›PMID 41109258›Full record

Observational studyThe Lancet. Global health2025

Screening for asymptomatic tuberculosis among adults with household exposure to pulmonary tuberculosis: a prospective observational cohort study.

Simon C Mendelsohn, Humphrey Mulenga, Michele Tameris, Tumelo Moloantoa, Stephanus T Malherbe, Austin Katona, Fernanda Maruri, Firdows Noor, Ravindre Panchia, Khuthadzo Hlongwane and 10 more

Erratum issuedAbstract readObservational Study
In one paragraph

Observational study in The Lancet. Global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The role of medical imaging in translational research into early pulmonary tuberculosis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Reported Tuberculosis Symptoms: An Inadequate Classifier of Disease State.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  16. Article
  17. Review
  18. Article
  19. Tongue swabmedRxiv : the preprint server for health sciences · 2026
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Simon C MendelsohnSouth African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa. Electronic address: Simon.mendelsohn@uct.ac.za.
Humphrey MulengaSouth African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Michele TamerisSouth African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Tumelo MoloantoaPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Stephanus T MalherbeDST/NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Immunology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Austin KatonaVanderbilt Tuberculosis Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Fernanda MaruriVanderbilt Tuberculosis Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Firdows NoorDST/NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Immunology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Ravindre PanchiaPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Khuthadzo HlongwanePerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Kim StanleyDST/NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Immunology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Yuri F van der HeijdenVanderbilt Tuberculosis Center, Vanderbilt University Medical Center, Nashville, TN, USA; The Aurum Institute, Johannesburg, South Africa.
Katie HadleySouth African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Dominique T AriefdienSouth African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Novel N ChegouDST/NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Immunology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Gerhard WalzlDST/NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Immunology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Thomas J ScribaSouth African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Timothy R SterlingVanderbilt Tuberculosis Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Mark HatherillSouth African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
RePORT South Africa Study Team

Funding

Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)U01AI152075 · NIAID · STELLENBOSCH UNIVERSITY · PI BELISLE, JOHN T, SUTHERLAND, JAYNE · 2020 to 2025
$7.1M
NIAID NIH HHS U01 AI152075
6 · The paper itself

Abstract

backgroundMore than half of tuberculosis cases detected by community prevalence surveys are classified as asymptomatic. We evaluated yield of symptom and chest radiograph screening of tuberculosis-exposed household contacts in South Africa.

methodsFor this prospective observational cohort study, adult volunteers (aged ≥18 years) with household exposure within the past 6 months to patients with untreated or partially treated pulmonary tuberculosis, identified through local health services, were enrolled at three sites in South Africa (Worcester and Ravensmead, Western Cape Province, and Soweto, Gauteng Province). Household contacts were excluded if they were unlikely to attend study visits, or had conditions interfering with consent or study participation, including psychiatric illness, substance dependence, or incarceration. Systematic screening of tuberculosis symptoms (any duration), chest radiograph (any abnormality indicative of active tuberculosis), and sputum microscopy, Xpert Ultra, and liquid culture were performed. Serum C-reactive protein (CRP) was measured by multiplex bead array. Prevalent tuberculosis was microbiologically confirmed (Xpert Ultra or culture). Symptomatic and asymptomatic tuberculosis were defined as prevalent tuberculosis with and without reported symptoms compatible with tuberculosis. The primary outcome was the diagnostic yield (sensitivity) of microbiologically confirmed pulmonary tuberculosis.

findingsBetween April 22, 2021 and Sept 22, 2022, 979 household contacts were enrolled, 345 (35·2%) male and 634 (64·8%) female, 185 (18·9%) living with HIV and 187 (19·1%) with previous tuberculosis. Prevalent tuberculosis occurred in 51 (5·2%) and was asymptomatic in 42 (82·4%) of 51. Only 13 (31·0%) of 42 asymptomatic people with tuberculosis were sputum-smear positive; eight (61·5%) of these 13 had a low bacillary burden, with smear grades scanty or 1+ (1-99 acid-fast bacilli per 100 fields). CRP did not discriminate healthy household contacts from those with asymptomatic tuberculosis (area under the curve 0·60, 95% CI 0·47-0·73). An abnormal chest radiograph suggestive of tuberculosis was observed in 23 of 41 asymptomatic (sensitivity 56·1%, 95% CI 41·0-70·1) versus eight of nine symptomatic (sensitivity 88·9%, 56·5-98·0) people with tuberculosis. Sensitivity of chest radiograph in combination with symptom screening was 32 (64·0%) of 50 (50·1-75·9) for all prevalent tuberculosis.

interpretationMore than 80% of confirmed people with tuberculosis among household contacts were asymptomatic; chest radiograph screening missed more than 40% of these. Community prevalence surveys reliant on symptom-based and chest radiograph-based approaches might substantially underestimate the prevalence of asymptomatic tuberculosis in endemic countries.

fundingRegional Prospective Observational Research for Tuberculosis South Africa through funding from the US National Institutes of Health, the Civilian Research and Development Foundation, and the South African Medical Research Council.

Indexed as

Asymptomatic InfectionsMass ScreeningTuberculosis, PulmonaryAdolescentAdultFamily CharacteristicsFemaleHumansMaleMiddle AgedPrevalenceProspective StudiesSouth AfricaSputumYoung Adult

Identifiers

PMID41109258
PMCPMC12643944

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.